|
|
| Research article summary (published 30 Mar 2008): |
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.
Full Abstract
BACKGROUND: Although the human leukocyte antigen (HLA)-B*5701 is highly associated with a hypersensitivity reaction (HSR) to abacavir (ABC), variable sensitivities have been reported when clinical data alone have been used to define an ABC HSR. This study evaluated the sensitivity of detection of the HLA-B*5701 allele as a marker of ABC HSRs in both white and black patients, using skin patch testing to supplement clinical diagnosis. METHODS: White and black patients, identified through chart review, were classified as having received a diagnosis of an ABC HSR based on clinical findings only (a clinically suspected ABC HSR) or based on clinical findings and a positive skin patch test result (an immunologically confirmed [IC] ABC HSR). Control subjects were racially matched subjects who tolerated ABC for >/=12 weeks without experiencing an ABC HSR. Patients and control subjects were tested for the presence of HLA-B*5701. Sensitivity, specificity, and odds ratios for the detection of HLA-B*5701 as a marker for an ABC HSR were calculated for white and black participants. RESULTS: Forty-two (32.3%) of 130 white patients and 5 (7.2%) of 69 black patients who met the criteria for clinically suspected HSRs had IC HSRs. All 42 white patients with IC HSRs were HLA-B*5701 positive (sensitivity, 100%; odds ratio, 1945; 95% confidence interval, 110-34,352). Among all white patients with clinically suspected HSRs, sensitivity was 44% (57 of 130 patients tested positive for HLA-B*5701); specificity among white control subjects was 96%. Five of 5 black patients with IC HSRs were HLA-B*5701 positive (sensitivity, 100%; odds ratio, 900; 95% confidence interval, 38-21,045). Among black patients with clinically suspected HSRs, the sensitivity was 14% (10 of 69 tested positive for HLA-B*5701); specificity among black control subjects was 99%. CONCLUSIONS: Although IC ABC HSRs are uncommon in black persons, the 100% sensitivity of HLA-B*5701 as a marker for IC ABC HSRs in both US white and black patients suggests similar implications of the association between HLA-B*5701 positivity and risk of ABC HSRs in both races.
Author information
Author/s: Saag, Michael (M); Balu, Rukmini (R); Phillips, Elizabeth (E); Brachman, Philip (P); Martorell, Claudia (C); Burman, William (W); Stancil, Britt (B); Mosteller, Michael (M); Brothers, Cindy (C); Wannamaker, Paul (P); Hughes, Arlene (A); Sutherland-Phillips, Denise (D); Mallal, Simon (S); Shaefer, Mark (M); Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team;
Affiliation: Center for AIDS Research, University of Alabama at Birmingham, Birmingham, USA.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis), published in United States. (Language: eng)
Reference: 2008-Apr; vol 46 (issue 7) : pp 1111-8
Dates: Created 2008/04/30; Completed 2008/06/17;
PMID: 18444831, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards.
30 Oct 2007 - Abacavir hypersensitivity reaction.
29 Apr 2002 - Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?
24 May 2006 - Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience.
28 Nov 2007 - Abacavir hypersensitivity reaction predicted by genetic test.
24 Mar 2004 - Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility.
9 Mar 2008 - Pharmacogenetic information derived from analysis of HLA alleles.
30 Jan 2008 - HLA-B*5701 and abacavir hypersensitivity.
30 Oct 2004 - Abacavir hypersensitivity: a model system for pharmacogenetic test adoption.
29 Nov 2008 - A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.
29 Apr 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.